Visceral obesity effect on prescription usage stratified by body-mass index category.

<p>Visceral obesity effect on prescription usage stratified by body-mass index category.</p>

Saved in:

Bibliographic Details
Main Author:	Maximino Acevedo-Fernández (20660802) (author)
Other Authors:	Renata Ochoa Precoma (20660805) (author), Leonardo M. Porchia (10367121) (author), Victor M. Posadas (20660808) (author), Enrique Torres-Rasgado (7889363) (author), M. Elba Gonzalez-Mejia (10367127) (author), Esther López-Bayghen (65969) (author)
Published:	2025
Subjects:	Medicine Cell Biology Genetics Molecular Biology Biotechnology Evolutionary Biology Developmental Biology Marine Biology Cancer Mental Health Infectious Diseases Virology Computational Biology ≥ 100 cm visceral adipose tissue fold increase ), fold increase ). normal weight participants 7 &# 8211 2018 </ p xlink "> vatob 5 &# 8211 4 &# 8211 3 &# 8211 001 ), specifically 0 &# 8211 augmented prescription use ≥ 1 prescription 7 %, p overall prescription use prescription use augmented rate 001 ). obese participants 952 participants versus 36 vatob demonstrated similar results sectional study rxq_rx files research focused ray absorptiometry odds ratios nhanes dataset many diseases logistic regression hematopoietic agents confidence intervals classified according central obesity
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items